To include your compound in the COVID-19 Resource Center, submit it here.

Pyridorin: Completed Phase IIb enrollment

NephroGenex completed enrollment of 317 patients in a double-blind, international Phase IIb trial

Read the full 135 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE